Protagenic Therapeutics, Inc.\new Increase (Decrease) in Accounts Payable and Accrued Liabilities
Protagenic Therapeutics, Inc.\new (PTIX) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $174.09 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2025-05-13
- Protagenic Therapeutics, Inc.\new increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-03-31 was $174.09K.
- Protagenic Therapeutics, Inc.\new increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2024-12-31 was $218.59K.
- Protagenic Therapeutics, Inc.\new increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2024-09-30 was $107.79K.
- Protagenic Therapeutics, Inc.\new increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2024-06-30 was $345.90K.
- Protagenic Therapeutics, Inc.\new increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $463.13K.
- Protagenic Therapeutics, Inc.\new increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was -$183.83K.
- Protagenic Therapeutics, Inc.\new increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was -$91.60K, a 126.93% decline from fiscal 2021.
- Protagenic Therapeutics, Inc.\new increase (decrease) in accounts payable and accrued liabilities for fiscal 2021 was $340.12K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-03-31 | $174.09K 10-Q · filed 2025-05-13 | $392.69K derived: sum of 2 quarters · filed 2025-05-13 | $500.48K derived: sum of 3 quarters · filed 2025-05-13 | $846.38K derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2024-12-31 | $218.59K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $326.38K derived: sum of 2 quarters · filed 2025-03-31 | $672.28K derived: sum of 3 quarters · filed 2025-03-31 | $463.13K 10-K · filed 2025-03-31 | |||
| 2024-09-30 | $107.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $453.69K derived: sum of 2 quarters · filed 2024-11-14 | $244.53K 10-Q · filed 2024-11-14 | $72.24K derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2024-06-30 | $345.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $136.74K 10-Q · filed 2024-08-14 | -$35.55K derived: sum of 3 quarters · filed 2025-05-13 | -$151.47K derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2024-03-31 | -$209.16K 10-Q · filed 2025-05-13 | -$381.45K derived: sum of 2 quarters · filed 2025-05-13 | -$497.37K derived: sum of 3 quarters · filed 2025-05-13 | -$500.20K derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | -$172.29K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$288.21K derived: sum of 2 quarters · filed 2025-03-31 | -$291.04K derived: sum of 3 quarters · filed 2025-03-31 | -$183.83K 10-K · filed 2025-03-31 | -$27.33K 10-K · filed 2024-04-01 | ||
| 2023-09-30 | -$115.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$118.75K derived: sum of 2 quarters · filed 2024-11-14 | -$11.54K 10-Q · filed 2024-11-14 | $109.30K 10-Q · filed 2023-11-14 | $134.01K derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | -$2.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $104.38K 10-Q · filed 2024-08-14 | $334.79K 10-Q · filed 2023-08-14 | $249.94K derived: sum of 3 quarters · filed 2024-08-14 | $343.45K derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $107.21K 10-Q · filed 2024-05-15 | $252.77K derived: sum of 2 quarters · filed 2024-05-15 | $346.28K derived: sum of 3 quarters · filed 2024-05-15 | $27.18K derived: sum of 4 quarters · filed 2024-05-15 | |||
| 2022-12-31 | $145.56K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-05-14 | $239.07K derived: sum of 2 quarters · filed 2024-05-14 | -$80.03K derived: sum of 3 quarters · filed 2024-05-14 | -$91.60K 10-K/A · filed 2024-05-14 | |||
| 2022-09-30 | $93.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$225.58K derived: sum of 2 quarters · filed 2023-11-14 | -$237.15K 10-Q · filed 2023-11-14 | -$135.10K derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | -$319.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$330.66K 10-Q · filed 2023-08-14 | -$228.61K derived: sum of 3 quarters · filed 2023-08-14 | -$84.82K derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | -$11.57K 10-Q · filed 2023-05-15 | $90.48K derived: sum of 2 quarters · filed 2023-05-15 | $234.27K derived: sum of 3 quarters · filed 2023-05-15 | $249.78K derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $102.05K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $245.84K derived: sum of 2 quarters · filed 2023-03-31 | $261.34K derived: sum of 3 quarters · filed 2023-03-31 | $340.12K 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $143.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $159.29K derived: sum of 2 quarters · filed 2022-11-14 | $238.07K 10-Q · filed 2022-11-14 | $285.74K derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $15.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $94.28K 10-Q · filed 2022-08-11 | $141.95K derived: sum of 3 quarters · filed 2022-08-11 | $157.97K derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | $78.78K 10-Q · filed 2022-05-13 | $126.45K derived: sum of 2 quarters · filed 2022-05-13 | $142.47K derived: sum of 3 quarters · filed 2022-05-13 | $92.62K derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2020-12-31 | $47.67K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-07 | $63.69K derived: sum of 2 quarters · filed 2022-04-07 | $13.85K derived: sum of 3 quarters · filed 2022-04-07 | -$196.63K 10-K · filed 2022-04-07 | |||
| 2020-09-30 | $16.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$33.83K derived: sum of 2 quarters · filed 2021-11-15 | -$244.30K 10-Q · filed 2021-11-15 | $334.73K derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | -$49.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$260.32K 10-Q · filed 2021-08-16 | $318.71K derived: sum of 3 quarters · filed 2021-08-16 | $306.08K derived: sum of 4 quarters · filed 2021-08-16 | |||
| 2020-03-31 | -$210.47K 10-Q · filed 2021-05-17 | $368.55K derived: sum of 2 quarters · filed 2021-05-17 | $355.92K derived: sum of 3 quarters · filed 2021-05-17 | $484.35K derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $579.03K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $566.40K derived: sum of 2 quarters · filed 2021-03-25 | $694.82K derived: sum of 3 quarters · filed 2021-03-25 | $662.16K 10-K · filed 2021-03-25 | |||
| 2019-09-30 | -$12.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $115.79K derived: sum of 2 quarters · filed 2020-11-16 | $83.13K 10-Q · filed 2020-11-16 | $57.71K derived: sum of 4 quarters · filed 2020-11-16 | |||
| 2019-06-30 | $128.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $95.76K 10-Q · filed 2020-08-14 | $70.34K derived: sum of 3 quarters · filed 2020-08-14 | $204.42K derived: sum of 4 quarters · filed 2020-08-14 | |||
| 2019-03-31 | -$32.66K 10-Q · filed 2020-06-18 | -$58.08K derived: sum of 2 quarters · filed 2020-06-18 | $76.00K derived: sum of 3 quarters · filed 2020-06-18 | $116.82K derived: sum of 4 quarters · filed 2020-06-18 | |||
| 2018-12-31 | -$25.42K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-29 | $108.66K derived: sum of 2 quarters · filed 2020-04-29 | $149.48K derived: sum of 3 quarters · filed 2020-04-29 | $98.59K 10-K · filed 2020-04-29 | |||
| 2018-09-30 | $134.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $174.90K derived: sum of 2 quarters · filed 2019-11-14 | $124.00K 10-Q · filed 2019-11-14 | $158.53K derived: sum of 4 quarters · filed 2019-11-14 | |||
| 2018-06-30 | $40.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$10.08K 10-Q · filed 2019-08-14 | $24.45K derived: sum of 3 quarters · filed 2019-08-14 | $51.33K derived: sum of 4 quarters · filed 2019-08-14 | |||
| 2018-03-31 | -$50.89K 10-Q · filed 2019-05-16 | -$16.37K derived: sum of 2 quarters · filed 2019-05-16 | $10.52K derived: sum of 3 quarters · filed 2019-05-16 | $58.53K derived: sum of 4 quarters · filed 2019-05-16 | |||
| 2017-12-31 | $34.52K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $61.41K derived: sum of 2 quarters · filed 2019-03-29 | $109.42K derived: sum of 3 quarters · filed 2019-03-29 | $17.26K 10-K · filed 2019-03-29 | -$17.26K 10-K · filed 2018-04-02 | ||
| 2017-09-30 | $26.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $74.90K derived: sum of 2 quarters · filed 2018-11-08 | -$17.26K 10-Q · filed 2018-11-08 | -$39.38K derived: sum of 4 quarters · filed 2018-11-08 | |||
| 2017-06-30 | $48.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$44.15K 10-Q · filed 2018-08-14 | -$66.27K derived: sum of 3 quarters · filed 2018-08-14 | -$21.98K derived: sum of 4 quarters · filed 2018-08-14 | |||
| 2017-03-31 | -$92.16K 10-Q · filed 2018-05-15 | -$114.28K derived: sum of 2 quarters · filed 2018-05-15 | -$69.99K derived: sum of 3 quarters · filed 2018-05-15 | -$156.32K derived: sum of 4 quarters · filed 2018-05-15 | |||
| 2016-12-31 | -$22.12K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $22.17K derived: sum of 2 quarters · filed 2018-04-02 | -$64.16K derived: sum of 3 quarters · filed 2018-04-02 | -$52.25K 10-K · filed 2018-04-02 | $52.25K 10-K · filed 2017-04-18 | ||
| 2016-09-30 | $44.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$42.04K derived: sum of 2 quarters · filed 2017-11-13 | -$30.13K 10-Q · filed 2017-11-13 | -$12.13K derived: sum of 4 quarters · filed 2017-11-13 | |||
| 2016-06-30 | -$86.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$74.42K 10-Q · filed 2017-08-08 | -$56.42K derived: sum of 3 quarters · filed 2017-08-08 | -$50.42K derived: sum of 4 quarters · filed 2017-08-08 | |||
| 2016-03-31 | $11.91K 10-Q · filed 2017-05-15 | $29.91K derived: sum of 2 quarters · filed 2017-05-15 | $35.91K derived: sum of 3 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | $18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-03-11 | $24.00K 10-Q · filed 2016-03-11 | $154.75K 10-K/A · filed 2017-05-08 | $154.53K 8-K/A · filed 2016-07-12 | |||
| 2015-09-30 | $6.00K 10-Q · filed 2015-11-13 | $51.89K 10-Q · filed 2016-11-17 | |||||
| 2015-06-30 | -$5.42K 10-Q · filed 2016-08-15 | ||||||
| 2014-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-03-11 | $26.00K 10-Q · filed 2016-03-11 | $15.42K 8-K/A · filed 2016-07-12 | ||||
| 2014-09-30 | $26.00K 10-Q · filed 2015-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |